Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer
Clin. transl. oncol. (Print)
; 25(11): 3139-3151, 11 nov. 2023. tab, ilus
Article
em En
| IBECS
| ID: ibc-226839
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Lung cancer (LC) is associated with ageing, with the average age of affected individuals being approximately 70 years. However, despite a higher incidence and prevalence among older people, the older adult population is underrepresented in clinical trials. For LC with Epidermal Growth Factor Receptor (EGFR) mutations, there is no clear association of this mutation with age. Geriatric assessments (GAs) and a multidisciplinary approach are essential for defining the optimal treatment. In this consensus, a group of experts selected from the Oncogeriatrics Section of the Spanish Society of Medical Oncology (Sección de Oncogeriatría de la Sociedad Española de Oncología MédicaSEOM), the Spanish Lung Cancer Group (Grupo Español de Cáncer de PulmónGECP) and the Association for Research on Lung Cancer in Women (Asociación para la Investigación del Cáncer de Pulmón en MujeresICAPEM) evaluate the scientific evidence currently available and propose a series of recommendations to optimize the management of older adult patients with advanced LC with EGFR mutations (AU)
Palavras-chave
Texto completo:
1
Coleções:
06-national
/
ES
Base de dados:
IBECS
Assunto principal:
Carcinoma Pulmonar de Células não Pequenas
/
Neoplasias Pulmonares
Limite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2023
Tipo de documento:
Article